Show simple item record

dc.contributor.authorBrocklesby, KL
dc.contributor.authorWaby, JS
dc.contributor.authorCawthorne, C
dc.contributor.authorSmith, G
dc.date.accessioned2017-03-24T14:22:54Z
dc.date.issued2017-04
dc.identifier.citationTetrahedron letters, 2017, 58 (15), pp. 1467 - 1469
dc.identifier.issn0040-4039
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/497
dc.identifier.doi10.1016/j.tetlet.2017.02.082
dc.description.abstractVandetanib is an orally available tyrosine kinase inhibitor used in the treatment of cancer. The current synthesis proceeds <i>via</i> an unstable 4-chloroquinazoline, using harsh reagents, in addition to requiring sequential protection and deprotection steps. In the present work, use of the Dimroth rearrangement in the key quinazoline forming step enabled the synthesis of Vandetanib in nine steps (compared to the previously reported 12-14).
dc.formatPrint
dc.format.extent1467 - 1469
dc.languageeng
dc.language.isoeng
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.titleAn alternative synthesis of Vandetanib (Caprelsa™) <i>via</i> a microwave accelerated Dimroth rearrangement.
dc.typeJournal Article
dcterms.dateAccepted2017-02-27
rioxxterms.versionofrecord10.1016/j.tetlet.2017.02.082
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2017-04
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfTetrahedron letters
pubs.issue15
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Closed research teams
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Closed research teams/PET Radiochemistry
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Closed research teams
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Closed research teams/PET Radiochemistry
pubs.publication-statusPublished
pubs.volume58en_US
pubs.embargo.termsNot known
icr.researchteamPET Radiochemistryen_US
dc.contributor.icrauthorSmith, Grahamen


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0